TONYPHARMA LIMITED

Company Registration Number:
09596100 (England and Wales)

Unaudited micro entity accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

TONYPHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

TONYPHARMA LIMITED

Company Information

for the Period Ended 31 May 2024




Director: Tony Addai
Secretary: Malaika Addai
Registered office: 14 Siddons Road
Siddons Road
London
England
N17 9UT
Company Registration Number: 09596100 (England and Wales)

TONYPHARMA LIMITED

Directors' Report Period Ended 31 May 2024

The directors present their report with the financial statements of the company for the period ended 31 May 2024

Principal Activities

Provision of pharmaceutical and medical services

Political and charitable donations

The company made no charitable donations under the year of review.

Company policy on the employment of disabled persons

It is the company's policy to give employment to disabled persons whenever practicable. the company offers equal opportunities to individuals without discrimination. At the present period under review, there were no persons with disabilities employed by the company.

Directors

The directors shown below have held office during the whole of the period from 01 June 2023 to 31 May 2024
Tony Addai

Secretary
Malaika Addai

This report was approved by the board of directors on 27 February 2025
And Signed On Behalf Of The Board By:

Name: Tony Addai
Status: Director

TONYPHARMA LIMITED

Profit and Loss Account

for the Period Ended 31 May 2024


2024
£

2023
£
Gross turnover (not including turnover from inside OPW engagements) 0 0
Gross turnover from inside OPW engagements 1,258 0
Deductions from gross turnover from inside OPW engagements ( 0 ) ( 0 )
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 300 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 0 ) ( 0 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period 958 0

TONYPHARMA LIMITED

Balance sheet

As at 31 May 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 280 250
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 280 250
Total assets less current liabilities: 280 250
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 280 250
Capital and reserves: 280 250

TONYPHARMA LIMITED

Balance sheet continued

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 27 February 2025
And Signed On Behalf Of The Board By:

Name: Tony Addai
Status: Director

The notes form part of these financial statements

TONYPHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 May 2024

  • 1. Employee Information

    Average number of employees: 1

TONYPHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 May 2024

  • 2. Off balance sheet disclosure

    No